Mail

The Fight Against COVID19

1.34k followers • 13 symbols Watchlist by TREA

Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.

13 symbols

Zacks
The Zacks Analyst Blog Highlights: Grocery Outlet, Sprouts Farmers, PLDT, Regeneron and Clorox
The Zacks Analyst Blog Highlights: Grocery Outlet, Sprouts Farmers, PLDT, Regeneron and Clorox
Zacks
Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
Is Moderna (MRNA) Stock Outpacing Its Medical Peers This Year?
Is (MRNA) Outperforming Other Medical Stocks This Year?
Zacks
S&P Sees Worst-Ever Q1: 5 Stocks That Gained in the ETF
Though all 11 sectors in the S&P 500 index were down in the quarter, information technology and healthcare fared better than others.
Zacks
Will Moderna Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor Moderna
Zacks
Top Stock Trades to Beat Coronavirus Blues in April
The coronavirus pandemic has hit markets bad. But investors shouldn't shun stocks in April but should instead look for avenues to invest in areas under focus owing to rise in infected cases.
Zacks
6 Top S&P 500 Stocks That Have Surged Despite Worst-Ever Q1
The disappointing performance in Q1 is not due to any economic, financial or geopolitical factors but instead a health hazard ??? the coronavirus pandemic.
Financial Times
US drugs regulator calls for halt to Zantac sales
The US drugs regulator has requested the heartburn drug Zantac be pulled from the market amid an investigation into whether the medicine made by Sanofi could be contaminated with a carcinogen. The Food and Drug Administration said on Wednesday that it had discovered that a cancer-causing impurity in some products based on ranitidine, known by the brand name Zantac, increases over time and when stored at higher temperatures. The agency said this may “result in consumer exposure to unacceptable levels of this impurity”.
Financial Times
Will big tobacco save us from the coronavirus?
Before today, searching Google for “coronavirus” and “bats” mostly delivered epidemiological research papers and some pretty grim looking soup. Mindful that it’s April 1 we emailed BAT’s flacks (that’s £65bn British American Tobacco), who assured that it’s “100 per cent legitimate”. BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing.
Zacks
Johnson & Johnson (JNJ) Stock Moves -1.48%: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $131.04, moving -1.48% from the previous trading session.
Zacks
Buy this High-Yield Large Cap Pharma Stock for Income Amid Coronavirus
AbbVie (ABBV) stock popped on Tuesday. This is part of the global pharmaceutical giant's larger 20% surge in the last week as the market tries to mount a comeback amid the coronavirus uncertainty...
Zacks
AbbVie (ABBV) Gains As Market Dips: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $76.11, moving +1.16% from the previous trading session.
Zacks
Gilead Sciences (GILD) Stock Moves -1.54%: What You Should Know
In the latest trading session, Gilead Sciences (GILD) closed at $74.76, marking a -1.54% move from the previous day.
Zacks
Pfizer (PFE) Stock Moves -0.03%: What You Should Know
Pfizer (PFE) closed at $32.66 in the latest trading session, marking a -0.03% move from the prior day.
Zacks
The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie
The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie
Zacks
Top Ranked Income Stocks to Buy for March 31st
Top Ranked Income Stocks to Buy for March 31st
Zacks
Gilead Expands Access to Experimental Coronavirus Treatment
Gilead (GILD) looks to expand access programs to accelerate access to remdesivir for COVID-19 patients.
Zacks
Company News for Mar 31, 2020
Companies In The News Are: SPCB, OMI, CVU, REGN
Zacks
J&J Plans to Initiate Coronavirus Vaccine Study in September
J&J (JNJ) announces its plan to start an early-stage clinical study on its selected vaccine candidate in September. The company also expands agreement with BARDA to accelerate vaccine development.
Zacks
Sanofi (SNY) Catches Eye: Stock Jumps 5.3%
Sanofi (SNY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Zacks
Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar?
Style Box ETF report for JKF
Investing.com
AbbVie Stock Rises 3%
Investing.com - AbbVie (NYSE:ABBV) Stock rose by 3.13% to trade at $77.68 by 11:43 (15:43 GMT) on Tuesday on the NYSE exchange.
Zacks
5 Top Momentum Stocks for April Amid Coronavirus-Led Turmoil
A handful of stocks have withstood the market mayhem in March, some of them are momentum players.
Financial Times
FirstFT: Today’s top news
A multiyear mergers and acquisitions boom ground to a halt in March as the coronavirus pandemic ravaged share prices and redirected executives’ focus towards saving their companies instead of trying to buy others. One executive who has not been deterred: BlackRock’s Larry Fink, who raised the prospect of a return to dealmaking in a letter to shareholders on Monday, writing that the world’s largest asset manager’s “work is not done” despite the upheaval in financial markets.
Zacks
Moderna (MRNA) Gains But Lags Market: What You Should Know
Moderna (MRNA) closed the most recent trading day at $30.48, moving +1.43% from the previous trading session.